Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
KDMF
0
NDC API
0
VMF
0
FDF
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 1,3-bis(1-(7-chloro-4'-quinolyl)-4'-piperazinyl)propane
2. Piperaquine
3. Piperaquine Phosphate (1:1)
4. Piperaquine Phosphate (1:4) Anhydrous
5. Piperaquine Tetraphosphate Anhydrous
6. Piperaquine Tetraphosphate Tetrahydrate
7. Quinoline, 4,4'-(1,3-propanediyldi-4,1-piperazinediyl)bis(7-chloro-)
8. Quinoline, 4,4'-(1,3-propanediyldi-4,1-piperazinediyl)bis(7-chloro-, Phosphate (1:1)
9. Quinoline, 4,4'-(1,3-propanediyldi-4,1-piperazinediyl)bis(7-chloro-, Phosphate (1:4)
10. Quinoline, 4,4'-(1,3-propanediyldi-4,1-piperazinediyl)bis(7-chloro-, Phosphate, Hydrate (1:4:4)
1. 85547-56-4
2. 5a17bat3gk
3. Piperaquine (phosphate)
4. Piperaquine Phosphate (1:1)
5. 4,4'-(1,3-propanediyldi-4,1-piperazinediyl)bis(7-chloroquinoline) Phosphate
6. 1215783-76-8
7. Unii-5a17bat3gk
8. Chembl539666
9. Schembl16101632
10. Hy-b1896a
11. Ex-a400
12. Dtxsid601006108
13. Bcp11808
14. S5355
15. Akos015896507
16. Ccg-270293
17. Sb19151
18. As-10594
19. Cs-0014403
20. 951p979
21. A841358
22. 1,3-bis(4-(7-chloroquinolin-4-yl)piperazin-1-yl)propane Phosphate
23. 1,3-bis(4-(7-chloroquinolin-4-yl)piperazin-1-yl)propane Xphosphate
24. 1,3-bis(4-(7-chloroquinolin-4-yl)piperazin-1-yl)propanephosphate
25. 4,4'-(1,3-propanediyldi-4,1-piperazinediyl)bis(7-chloroquinoline)phosphate
26. Quinoline, 4,4'-(1,3-propanediyldi-4,1-piperazinediyl)bis(7-chloro-, Phosphate
27. Phosphoric Acid--4,4'-[propane-1,3-diyldi(piperazine-4,1-diyl)]bis(7-chloroquinoline) (1/1)
28. Quinoline, 4,4'-(1,3-propanediyldi-4,1-piperazinediyl)bis(7-chloro-, Phosphate (1:1)
Molecular Weight | 633.5 g/mol |
---|---|
Molecular Formula | C29H35Cl2N6O4P |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 10 |
Rotatable Bond Count | 6 |
Exact Mass | 632.1834460 g/mol |
Monoisotopic Mass | 632.1834460 g/mol |
Topological Polar Surface Area | 117 Ų |
Heavy Atom Count | 42 |
Formal Charge | 0 |
Complexity | 704 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Antimalarials
Agents used in the treatment of malaria. They are usually classified on the basis of their action against plasmodia at different stages in their life cycle in the human. (From AMA, Drug Evaluations Annual, 1992, p1585) (See all compounds classified as Antimalarials.)
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Piperaquine Phosphate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Piperaquine Phosphate, including repackagers and relabelers. The FDA regulates Piperaquine Phosphate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Piperaquine Phosphate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Piperaquine Phosphate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Piperaquine Phosphate supplier is an individual or a company that provides Piperaquine Phosphate active pharmaceutical ingredient (API) or Piperaquine Phosphate finished formulations upon request. The Piperaquine Phosphate suppliers may include Piperaquine Phosphate API manufacturers, exporters, distributors and traders.
click here to find a list of Piperaquine Phosphate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Piperaquine Phosphate written confirmation (Piperaquine Phosphate WC) is an official document issued by a regulatory agency to a Piperaquine Phosphate manufacturer, verifying that the manufacturing facility of a Piperaquine Phosphate active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Piperaquine Phosphate APIs or Piperaquine Phosphate finished pharmaceutical products to another nation, regulatory agencies frequently require a Piperaquine Phosphate WC (written confirmation) as part of the regulatory process.
click here to find a list of Piperaquine Phosphate suppliers with Written Confirmation (WC) on PharmaCompass.
Piperaquine Phosphate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Piperaquine Phosphate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Piperaquine Phosphate GMP manufacturer or Piperaquine Phosphate GMP API supplier for your needs.
A Piperaquine Phosphate CoA (Certificate of Analysis) is a formal document that attests to Piperaquine Phosphate's compliance with Piperaquine Phosphate specifications and serves as a tool for batch-level quality control.
Piperaquine Phosphate CoA mostly includes findings from lab analyses of a specific batch. For each Piperaquine Phosphate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Piperaquine Phosphate may be tested according to a variety of international standards, such as European Pharmacopoeia (Piperaquine Phosphate EP), Piperaquine Phosphate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Piperaquine Phosphate USP).
LOOKING FOR A SUPPLIER?